Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Catalog No. | Product Name | Size | List Price (US$) | Quantity |
---|
The manufacturing conditions of Remicade biosimilar from the CHO stable cell line need to be optimized by clients.
The cheapest research grade infliximab biosimilar protein (1 mg for >$30) is also available.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Infliximab (trade name Remicade, Janssen Biotech), a chimeric anti-TNF-α monoclonal antibody, is used to treat psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Infliximab interferes TNF-α from binding to its receptor in the cell.
Mainly produced by activated macrophages (M1), Tumor necrosis factor (TNF, cachexin, cachectin, tumor necrosis factor alpha, TNFα) plays important roles in the regulation of autoimmune reaction.
C011: Remicade Biosimilar Stable Cell Line (CHO)
The yield of Remicade biosimilar from the CHO stable cell line was above 1.5 g/L in flask.
The Remicade biosimilar stable cell line alone can be transfered alone or together with the technology of process development and/or antibody purification.
Syd Labs also provides the following anti-TNF antibody biosimilar stable cell line:
Humira Biosimilar Stable Cell Line
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.